Video Library

Solutions

May 22, 2023

1,4-Dioxane Bioremediation In Situ: Precision Delivery with the Allonnia 1,4 D-Stroy™ Solution

The detectives working in Allonnia’s labs have discovered naturally occuring bacterium with an affinity to derive their energy from 1,4-dioxane — metabolizing it into just water and carbon dioxide and rendering it completely harmless.

Nov 30, 2023

Surface Active Foam Fractionation: How it Removes PFAS

Allonnia partnered with EPOC Enviro to eliminate PFAS in North America with a naturally elegant solution called SAFF. See how the award-winning technology works and the breadth of its capabilities.

Events

May 23, 2023

Allonnia at SynBioBeta: Effectively Scaling Transformational Biology into Commercial Products

Allonnia’s CEO, Nicole Richards, shares how the company is developing a scalable platform and process driven methodology to drive synthetic biology solutions from the petri dish to commercial realities, as well as introduce Allonnia’s newest bio-ingenuity products through the lens of their commercial deployment.

October 22, 2024

Allonnia at MIT Sustainability Conference: Startup Exchange Lightning Talk

Kent Sorenson, Allonnia CTO, walks through the company’s exciting developments in recovering rare earth elements from mine-impacted water and other sources.

Solutions

May 22, 2023

1,4-Dioxane Bioremediation In Situ: Precision Delivery with the Allonnia 1,4 D-Stroy™ Solution

The detectives working in Allonnia’s labs have discovered naturally occuring bacterium with an affinity to derive their energy from 1,4-dioxane — metabolizing it into just water and carbon dioxide and rendering it completely harmless.

Nov 30, 2023

Surface Active Foam Fracationation: How it Removes PFAS

Allonnia partnered with EPOC Enviro to eliminate PFAS in North America with a naturally elegant solution called SAFF. See how the award-winning technology works and the breadth of its capabilities.

Events

May 23, 2023

Allonnia at SynBioBeta: Effectively Scaling Transformational Biology into Commercial Products

Allonnia’s CEO, Nicole Richards, shares how the company is developing a scalable platform and process driven methodology to drive synthetic biology solutions from the petri dish to commercial realities, as well as introduce Allonnia’s newest bio-ingenuity products through the lens of their commercial deployment.